Antiischemic Properties of Fasudil in Experimental Models of Vasospastic Angina
Authors:
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 87 (1) , 34-40
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 21 references indexed in Scilit:
- The Protein Kinase Inhibitor Fasudil Protects Against Ischemic Myocardial Injury Induced by Endothelin-1 in the RabbitJournal of Cardiovascular Pharmacology, 2000
- Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2000
- Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasmCardiovascular Research, 1999
- Inhibition of Neutrophil Migration by a Protein Kinase Inhibitor for the Treatment of Ischemic Brain InfarctionThe Japanese Journal of Pharmacology, 1999
- Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1βCirculation, 1997
- Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077European Journal of Pharmacology, 1995
- Effects of SR 49059, a non‐peptide antagonist of vasopressin V1areceptors, on vasopressin‐induced coronary vasoconstriction in conscious rabbitsFundamental & Clinical Pharmacology, 1995
- Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heartEuropean Journal of Pharmacology, 1991
- Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinaseBritish Journal of Pharmacology, 1989